Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A common antitussive drug, clobutinol, precipitates the long QT syndrome 2.

Molecular pharmacology - 1 Nov 2004

Bellocq Chloé, Wilders Ronald, Schott Jean-Jacques, Louérat-Oriou Bénédicte, Boisseau Pierre, Le Marec Hervé, Escande Denis, Baró Isabelle

Abstract excerpt

QT prolongation, a classic risk factor for arrhythmias, can result from a mutation in one of the genes governing cardiac repolarization and also can result from the intake of a medication acting as blocker of the cardiac K(+) channel human ether-a-go-go-related gene (HERG). Here, we identified th...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arrhythmias, Cardiac
Share to Electrophysiology
Share to Ether-A-Go-Go Potassium Channels

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Long QT Syndrome

Share to Potassium Channels, Voltage-Gated

Share to Proline

Share to Threonine

Share to Valine

Source

Identifiers

PMID: 15280442
DOI: 10.1124/mol.104.001065

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-15280442-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A common antitussive drug, clobutinol, precipitates the long QT syndrome 2.PMID 15280442Read ↗

QT interval prolongation and cardiac risk assessment for novel drugs.Semantic proximity Read ↗

Hydroxyzine, a first generation H(1)-receptor antagonist, inhibits human ether-a-go-go-related gene (HERG) current and causes syncope in a patient with the HERG mutation.Semantic proximity Read ↗

Dangerous and life-threatening drugs - practical lessons from the long QT syndrome.Semantic proximity Read ↗

Drug-induced torsades de pointes: the evolving role of pharmacogenetics.Semantic proximity Read ↗

Pharmacological targeting in inherited arrhythmia syndromes.Semantic proximity Read ↗

Translational toxicology and rescue strategies of the hERG channel dysfunction: biochemical and molecular mechanistic aspects.Semantic proximity Read ↗

Blockade of HERG K+ channel by an antihistamine drug brompheniramine requires the channel binding within the S6 residue Y652 and F656.Semantic proximity Read ↗

The action of the novel gastrointestinal prokinetic prucalopride on the HERG K+ channel and the common T897 polymorph.Semantic proximity Read ↗

Molecular predictors of drug-induced prolongation of the QT interval.Semantic proximity Read ↗

Medical Therapy for Long QT Syndrome.Semantic proximity Read ↗

Drug-induced arrhythmia: pharmacogenomic prescribing?Semantic proximity Read ↗

Propofol inhibits hERG K+ channels and enhances the inhibition effects on its mutations in HEK293 cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.